nach oben

Erschienen in:

01.02.2022 | Clinical study

PPIs or COX-2 inhibitors reduce risk of gastrointestinal ADRs from NSAID + anticoagulant use

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Adding a proton pump inhibitors (PPIs) or substituting non-selective non-steroidal anti-inflammatories (nsNSAIDs) with selective cyclo-oxygenase-2 (COX-2) inhibitors appears to reduce the risk of serious gastrointestinal (GI) adverse drug reactions (ADRs) in elderly patients requiring both anti-inflammatories and anticoagulants, according to findings published in Drug Safety. …

Lee J-Y, et al. Impact of Preventive Strategies on Gastrointestinal Complications in Elderly Patients on Concomitant Use of Oral Anticoagulants and Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Cohort Study. Drug Safety : 17 Feb 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01150-x

Titel: PPIs or COX-2 inhibitors reduce risk of gastrointestinal ADRs from NSAID + anticoagulant use
Publikationsdatum: 01.02.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-10435-2

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

PPIs or COX-2 inhibitors reduce risk of gastrointestinal ADRs from NSAID + anticoagulant use

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Levetiracetam

Levetiracetam

Immune-globulin/methylprednisolone/pembrolizumab

Antibacterials/antineoplastics

Plasma/tozinameran

Ciclosporin/tacrolimus